
1001-5000 employees
Natera is a global leader in cell-free DNA testing, specializing in non-invasive prenatal testing, oncology, and organ transplant rejection monitoring. Founded in 2004, the company leverages advanced genetic testing and proprietary technology to provide highly accurate and actionable insights for patients and healthcare providers. Natera's mission is to improve clinical outcomes through innovative genetic testing solutions that empower informed medical decisions. Their products include Panorama, a prenatal screening test, and Signatera, a personalized circulating tumor DNA test for cancer management. Natera is publicly traded on NASDAQ under the symbol NTRA and serves a broad market including clinical laboratories, hospitals, and research institutions.
6 months ago
📋
🎯
🏖️